Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Experimental Dermatology|August 4, 2009
Injury downregulates the expression of the human cathelicidin protein hCAP18/LL-37 in atopic dermatitisLotus Mallbris, Lina Carlén, Tianling Wei, et al.
European Journal of Epidemiology|May 1, 2004
Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatientsLotus Mallbris, Olof Akre, Fredrik Granath, et al.
Clinical and Experimental Rheumatology|December 24, 2014
Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trialBruce Kirkham, Kurt de Vlam, Wenzhi Li, et al.
Acta Dermato-Venereologica|April 1, 2014
Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy: results of the SCORE studyGiuseppe Micali, Dagmar Wilsmann-Theis, Lotus Mallbris, et al.
Acta Dermato-Venereologica|December 31, 2015
Economic Burden of Psoriasis and Potential Cost Offsets with Biologic Treatment: A Swedish Register AnalysisAxel Svedbom, Johan Dahlén, Carla Mamolo, et al.
JAMA Dermatology|November 20, 2024
Skin Inflammation, Systemic Inflammation, and Cardiovascular Disease in PsoriasisAxel Svedbom, Lotus Mallbris, Álvaro González-Cantero, et al.
The Lancet. Rheumatology|June 30, 2026
Predicting psoriatic arthritis in new-onset psoriasis: development of multivariable prediction models from an inception cohort studyAxel Svedbom, Lotus Mallbris, Alen Zabotti, et al.
Acta Dermato-Venereologica|March 14, 2015
Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register studyAxel Svedbom, Johan Dalén, Carla Mamolo, et al.
Pageof 7